Percutaneous absorption type cerebral protective agent
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 13, 2011
Grant Date -
Jun 28, 2007
app pub date -
Nov 12, 2003
filing date -
Nov 12, 2003
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A percutaneous absorption type cerebral protective agent containing as an active ingredient, 0.1 to 30 percent by mass of 3-methyl-1-phenyl-2-pyrazolin-5-one represented by the following formula:or a medically acceptable salt thereof in a base; a use of the compound as an active ingredient for the manufacture of a percutaneous absorption type pharmaceutical composition for protecting brain; and a method of protecting brain comprising administering to a patient the pharmaceutical composition as an active ingredient.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully